Citius pharmaceuticals, inc. announces 1-for-25 reverse stock split

Cranford, n.j. , nov. 22, 2024 /prnewswire/ -- citius pharmaceuticals, inc. ("citius pharma" or the "company") (nasdaq: ctxr) announced today that it will be executing a reverse stock split of its common stock, par value $0.001 per share, at a ratio of 1-for-25 ("reverse stock split").
CTXR Ratings Summary
CTXR Quant Ranking